Genotoxicity associated with the use of tyrosine kinase inhibitors in patients with chronic myeloid leukemia

Environ Mol Mutagen. 2018 Apr;59(3):260-262. doi: 10.1002/em.22164. Epub 2017 Dec 29.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Cross-Sectional Studies
  • DNA Damage / drug effects*
  • Female
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology*
  • Male
  • Middle Aged
  • Protein Kinase Inhibitors / pharmacology*
  • Treatment Outcome
  • Young Adult

Substances

  • Protein Kinase Inhibitors